News Daily News Echo Features Pinpoint Those Unlikely to Benefit From MitraClip Shelley Wood December 15, 2020
News Daily News ‘Frailty Meter’ May Aid Treatment Decisions in Chronic Limb-Threatening Ischemia L.A. McKeown November 24, 2020
News Conference News AHA 2020 Clopidogrel Should Remain Antiplatelet of Choice in Elective PCI: ALPHEUS Michael O'Riordan November 14, 2020
News Opinion Conversations in Cardiology Conversations in Cardiology: How to Juggle Two STEMIs at the Same Time November 09, 2020
News Daily News H. Pylori in ACS: Could Tests and Treatment Beat Back the Bleeds? Shelley Wood November 05, 2020
News Daily News Superiority of Ticagrelor Over Clopidogrel in ACS Questioned Todd Neale October 29, 2020
News Conference News TCT 2020 FFR Insights Before and After PCI: Fresh Food for Thought Caitlin E. Cox October 16, 2020
News Conference News TCT 2020 MitraBridge: Could a MitraClip Help Patients Avoid Heart Transplant? Shelley Wood October 16, 2020
News Conference News TCT 2020 Shorter DAPT Succeeds in Xience-Treated Patients at High Bleeding Risk Caitlin E. Cox October 15, 2020
News Conference News TCT 2020 MITHRAS: No Upside to Closing iASDs Caused by Transcatheter MV Interventions Shelley Wood October 15, 2020
News Conference News TCT 2020 Ticagrelor Monotherapy Following 3-Month DAPT Cuts Post-PCI Bleeding After STEMI Todd Neale October 14, 2020
News Conference News TCT 2020 Prophylactic PCI of Vulnerable Plaques? PROSPECT II/ABSORB Michael O'Riordan October 14, 2020
News Conference News HFSA 2020 Splanchnic Nerve Ablation Improves HFpEF Symptoms, QoL in FIH Study L.A. McKeown October 12, 2020
News Daily News Diabetes Influences Relative Effects of Ticagrelor, Prasugrel in ACS: ISAR-REACT 5 Todd Neale October 09, 2020
News Daily News TAVR Delays During Pandemic’s Peak Led to Hospitalizations, Deaths Michael O'Riordan September 30, 2020
News Daily News Document Proposes Procedure Volumes to Attain Competency in High-risk PCI Todd Neale September 22, 2020
News Daily News ‘Speaking the Same Language’: New Guidance for Trials of Patients at High Bleeding Risk Michael O'Riordan September 16, 2020